- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03986151
Anatomical sNuffbox for Coronary anGiography and IntervEntions (ANGIE)
March 9, 2021 updated by: Grigorios Tsigkas, University Hospital of Patras
This randomized, single-center, prospective study seeks to compare the conventional radial approach with the recently described distal radial approach (anatomical snuffbox) concerning the patency of the radial artery in patients subjected to coronary angiography or percutaneous coronary intervention.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Transradial approach has become the standard approach for coronary angiography (CAG) and percutaneous coronary intervention (PCI).
The current ESC/EACTS guidelines of myocardial revascularization support using radial approach (RA) rather than femoral approach (FA) if the operators are experts for RA.
Recently, an alternative transradial access has been suggested at the anatomical snuffbox, with potential additional benefits including a reduction in radial artery occlusion rate (which allows reintervention through the same access site and potential use as a graft), a decrease in other local vascular complications, shorter hemostasis duration, patients' intra and post procedural comfort and shorter recovery time.
However, the feasibility of PCI via snuffbox approach is still concerned due to the lack of data.
Therefore, the aim of the study is to compare the two approaches concerning the patency of the radial artery ≥30 days after the intervention with Doppler in a randomized way.
Due to the anastomosis of the distal radial artery with the superficial palmar arch, even in case of total radial artery occlusion within the anatomical snuffbox, the antegrade blood flow may be preserved and, therefore, decreased incidents of radial artery occlusion are expected in the right distal radial artery approach group.
The mean diameter of radial artery at the anatomical snuffbox is 2.4 mm, whereas the mean diameter of the radial artery at the forearm is 2.7 mm, and this could potentially contribute to shorter hemostasis duration.
Study Type
Interventional
Enrollment (Actual)
1042
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Achaia
-
Patras, Achaia, Greece, 26504
- University Hospital of Patras
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Indication for coronary angiography
- Informed consent
Exclusion Criteria:
- Non palpable right radial artery
- Prior complicated right transradial intervention (radial artery dissection, perforation, occlusion)
- Prior CABG
- STEMI
- Hemodynamic instability
- Anatomical restrictions (fistula, etc)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Conventional radial access
|
Comparison of the conventional radial approach with the distal radial approach (anatomical snuffbox)
|
|
EXPERIMENTAL: Distal radial access
|
Comparison of the conventional radial approach with the distal radial approach (anatomical snuffbox)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of right radial artery occlusion
Time Frame: ≥30 days after CAG or PCI
|
≥30 days after CAG or PCI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Fluoroscopy time
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Rate of successful insertion of the sheath
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Duration of sheath insertion procedure
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Rate of successful completion of coronary angiography
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Rate of successful completion of percutaneous coronary intervention
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Total Contrast volume
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Total Radiation Dose
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Total Procedure Time
Time Frame: Immediately post-procedurally
|
Immediately post-procedurally
|
|
|
Time required for hemostasis
Time Frame: 1-6 hours
|
1-6 hours
|
|
|
Postprocedural Hematoma (modified EASY class)
Time Frame: 3 hours
|
3 hours
|
|
|
Rate of distal radial artery occlusion
Time Frame: ≥30 days after CAG or PCI
|
≥30 days after CAG or PCI
|
|
|
Pain associated with the procedure: Pain scale 0-10
Time Frame: 1 hour
|
Pain scale 0-10.
A visual anlog pain scale 0-10 will be shown to the patient post-precedurally.
0=no pain, 10=worst pain.
Patient will be asked to report the severity of the pain associated with the procedure.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 11, 2019
Primary Completion (ACTUAL)
February 20, 2021
Study Completion (ACTUAL)
February 20, 2021
Study Registration Dates
First Submitted
June 11, 2019
First Submitted That Met QC Criteria
June 13, 2019
First Posted (ACTUAL)
June 14, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 12, 2021
Last Update Submitted That Met QC Criteria
March 9, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11994/6-5-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Coronary angiography +/- percutaneous coronary intervention
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece
-
University Hospital of PatrasRecruitingCoronary Artery Disease | ST Elevation Myocardial Infarction | Percutaneous Coronary Intervention | Coronary Catheterization | Distal Transradial Artery | Transradial Artery | Primary PCIBelgium, Greece, Switzerland
-
University Hospital, BordeauxCompletedCoronary Angiography | AngioplastyFrance
-
Terumo Europe N.V.CromsourceCompletedCoronary DiseaseItaly, Belgium, United Kingdom, Hungary, Japan, Czechia, Germany, Netherlands, North Macedonia, Switzerland
-
Assiut UniversityCompletedCoronary Artery DiseaseEgypt
-
Chinese PLA General HospitalUnknownPercutaneous Coronary Intervention | CHD - Coronary Heart Disease | In-stent RestenosisChina
-
424 General Military HospitalCompletedMyocardial Infarction | Coronary Artery DiseaseGreece
-
Lauri MansikkaniemiCompletedChronic Total Occlusion of Coronary Artery | Coronary Artery Disease (CAD) | Chronic Total Occlusion (CTO)Finland
-
ECRI bvBoston Scientific Corporation; Philips Healthcare; Cardialysis B.V.CompletedLeft Main Coronary Artery StenosisSpain, United Kingdom, Italy
-
Sahlgrenska University Hospital, SwedenUnknownAngina, Unstable | Non-ST Elevation Myocardial Infarction (NSTEMI)Sweden